Loading clinical trials...
Loading clinical trials...
The purpose of this study is to show that two FDA-approved botulinum toxin drugs called Xeomin® and Botox® can reduce the severity of vertical lines (wrinkles) that appear between the eyebrows (glabel...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Merz North America, Inc.
NCT05148000 · Glabellar Frown Lines, Canthal Lines
NCT05481931 · Glabellar Frown Lines
NCT03985982 · Glabellar Frown Lines
NCT06411002 · Glabellar Frown Lines
NCT05146999 · Glabellar Frown Lines
Merz Investigative Site #001099
Los Angeles, California
Merz Investigative Site #001300
Sacramento, California
Merz Investigative Site #001299
Santa Monica, California
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions